Zepbound_15mg

Zepbound 15mg: A Breakthrough in Weight Management

Zepbound 15mg, containing tirzepatide, is a once-weekly injectable medication approved for weight loss in adults with obesity or overweight conditions like type 2 diabetes. This dual-action GLP-1/GIP receptor agonist enhances insulin sensitivity and reduces appetite, leading to significant weight reduction. Clinical trials have shown that 15mg doses can result in up to 21% average weight loss over 72 weeks, with 91% of users losing at least 5% of their body weight. The dosing regimen starts at 2.5mg, increasing gradually to 15mg to minimize side effects such as nausea. Zepbound is most effective when combined with a reduced-calorie diet and increased physical activity.